聚乙二醇干扰素结合利巴韦林治疗慢性丙肝的临床护理体会

Clinical nursing experience of pegylated interferon combined with ribavirin in the treatment of chronic hepatitis C

ES评分 0

DOI 10.12208/j.jmnm.20250299
刊名
Journal of Modern Nursing MedicineJPCNS
年,卷(期) 2025, 4(6)
作者
作者单位

普洱市人民医院 云南普洱

摘要
目的 探析利巴韦林+聚乙二醇干扰素治疗慢性丙肝的护理研究。方法 2023年8月~2024年8月,取我院慢性丙肝患者76例,76例患者均接受利巴韦林+聚乙二醇干扰素治疗,均等随机分组,对照组38例+常规护理,观察组38例+优质护理,组间价值分析。结果 干预后,观察组肝功能、并发症、生活质量、满意度数值均较对照组更优(P<0.05)。结论 利巴韦林、聚乙二醇干扰素治疗慢性丙肝期间开展优质护理获显著效用,可借鉴、采纳。
Abstract
Objective To explore the nursing study of ribavirin + peginterferon in the treatment of chronic hepatitis C. Methods From August 2023 to August 2024,76 patients with chronic hepatitis C in our hospital, 76 patients received ribavirin + pegylated interferon treatment, equal randomization, control group 38 cases + routine care, 38 observation group + quality care, between-group value analysis. Results After the intervention, the values of liver function, complications, quality of life, and satisfaction were better than the control group (P <0.05). Conclusion Ribavirin and PEG interferon achieved significant effective during the treatment of chronic hepatitis C, which can be used for reference and adopted.
关键词
慢性丙肝;生活质量;聚乙二醇干扰素;肝功能
KeyWord
Chronic hepatitis C; Quality of life; Pegylated interferon; Liver function
基金项目
页码 59-61
  • 参考文献
  • 相关文献
  • 引用本文

肖红霞*,李波,段金丽. 聚乙二醇干扰素结合利巴韦林治疗慢性丙肝的临床护理体会 [J]. 现代护理医学杂志. 2025; 4; (6). 59 - 61.

  • 文献评论

相关学者

相关机构